Announcement.
WEBINAR: No more missed pathogens. One metagenomic method for all.
Enzymes that Unlock
Your Next Discovery
0
Viral Bioprocessing

Whitepaper: Efficient Chromatin Removal Viral Vector Manufacturing Using Salt-Active Nucleases

Introduction

The First Enzymatic Solution for Complete Removal of Chromatin at Physiological Salt Conditions and its Effect on Downstream Processing

This whitepaper can be downloaded in full here as a PDF and includes sections:

Abstract

The presence of chromatin-associated DNA in crude viral suspensions poses significant challenges for the downstream processing (DSP) of viral vectors. Traditional nucleases derived from Serratia marcescens, exhibit reduced activity under physiological salt conditions (~150 mM NaCl), leading to incomplete chromatin fragmentation.

Recent peer-reviewed studies evaluated the performance of M-SAN HQ, a nuclease specifically optimized for high activity at physiological salt concentrations, in the degradation of chromatin associated DNA from viral crude harvests.

These publications demonstrate that traditional nucleases not only digest DNA from crude harvests less efficiently than M-SAN HQ, but that the residual DNA is in the form of large chromatin structures causing problems in DSP. These publications show that M-SAN HQ efficiently fragments chromatin to sizes allowing easy removal in the DSP without additional salt. This not only improves the purity of the viral vector but also the potential to enhance DSP efficiency, increase yield, shorten processing times, and reduce costs in manufacturing therapeutic viruses.

References

  1. Pagallies, F., Labisch, J. J., Wronska, M., Pflanz, K. & Amann, R. Efficient and scalable clarification of Orf virus from HEK suspension for vaccine development. Vaccine X 18, 100474 (2024)
  2. Pereira Aguilar, P. et al. Capture and purification of Human Immunodeficiency Virus-1 virus-like particles: Convective media vs porous beads. J. Chromatogr. A 1627, 461378 (2020)
  3. Mayer, V. et al. Removal of chromatin by salt‐tolerant endonucleases for production of recombinant measles virus. Biotechnol. Prog. 39, e3342 (2023)
Subscribe to Newsletter.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
For Customer Support
For  Technical Support
Metagenomics

How an Accidental Error Helped Unlock Clinical Metagenomics [Video]

Explore the origins, challenges and breakthroughs shaping clinical metagenomics in this three-part series with Professor Justin O’Grady.
Read More
Viral Bioprocessing

CAR-T Breakthroughs and the Emerging Potential of In Vivo Therapy

Explore the latest CAR T advancements and the promising future of in vivo technologies. Discover their potential impact on cancer treatment.
Read More
Viral Bioprocessing

New Poster: Quantification Challenges of Chromatin—Associated Host Cell DNA: An Underestimated Risk

Presented at Advanced Therapies USA, Nov 2025 - Learn if you are significantly underestimating chromatin-associated host-cell DNA?
Read More
Lorem ipsum dolor

You're a scientist, so of course you have questions- Don't hesitate to contact us!